Table 1.
Age (years) | 70.1 ± 5.4 |
Gender (men) | 7 |
Years since diagnosis PD | 5.7 ± 3.3 |
Hoehn and Yahr stage (2/2.5/3) | 4/5/3 |
Walking aid in daily life (yes/no) | 3/9 |
Number of falls in previous 6 months (0/1/2/7) | 5/2/4/1 |
Education (possible range 1–7)a | 5.7 ± 1.3 |
MMSE (possible range 0–30)b | 27.4 ± 2.0 |
LAPAQ (kcals/day) | 630.3 ± 712.1 |
FES-I (possible range 16–64)c | 29.3 ± 8.2 |
Number of different medications used | 5.3 ± 2.7 |
Values are mean ± standard deviation or frequency
PD Parkinson’s disease, MMSE Mini-Mental State Examination, LAPAQ Longitudinal Aging Study Amsterdam Physical Activity Questionnaire, FES-I Fall Efficacy Scale International
aAccording to Verhage and colleagues [30]
bHigher scores indicating better global cognitive functioning
cHigher scores indicating more fear of falling